This laboratory proposes to continue its morphological and molecular biological studies of retinoblastoma and uveal melanoma and interface them with new technologies made available through recombinant DNA research. Specifically we plan the following studies: 1. We will study a transgenic mouse that develops heritable retinoblastoma due to the genomic integration of a gene coding for SV40 large T antigen. The morphology, molecular biologic features, site of large T antigen integration, and elucidation of transgenic regulatory elements will be determined. These studies should reveal similarities an differences between murine tumor and human retinoblastoma and will establish the transgenic mouse model's concordance with the human condition. 2. In situ hybridization will be utilized to study expression of retinoblastoma gene in developing mature retina and other tissues. Variations of expression for different cell types will be investigated in order to define the histogenesis of retinoblastoma and the role of the Rb gene in differentiating tissue. 3. We will assay for oncogene activations in naturally occurring human uveal melanoma and correlate presence of oncogene activation with cell type and prognosis. In addition we have described the inhibition of retinoblastoma growth by vitamin D compounds and sodium butyrate and we will continue to study potential therapeutic strategies in the transgenic mouse model of retinoblastoma.
| Burris, Christopher K H; Raven, Meisha L; Rodriguez, Maria E et al. (2017) Bilateral Primary Mucinous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg 33:S72-S73 |
| Rodriguez, Maria E; Burris, Christopher K; Kauh, Courtney Y et al. (2017) A Conjunctival Melanoma Causing Bloody Tears. Ophthal Plast Reconstr Surg 33:e77 |
| Kulkarni, A D; van Ginkel, P R; Darjatmoko, S R et al. (2009) Use of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model. Br J Ophthalmol 93:1105-8 |
| van Ginkel, Paul R; Yang, William; Marcet, Marcus M et al. (2007) 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol 85:255-62 |
| Albert, Daniel M; Scheef, Elizabeth A; Wang, Shoujian et al. (2007) Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci 48:2327-34 |
| Tolleson, William H; Doss, Jason C; Latendresse, John et al. (2005) Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice. Arch Ophthalmol 123:1088-94 |
| Albert, Daniel M; Kumar, Amit; Strugnell, Stephen A et al. (2004) Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model. Arch Ophthalmol 122:1365-9 |
| Albert, Daniel M; Kumar, Amit; Strugnell, Stephen A et al. (2004) Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models. Arch Ophthalmol 122:1357-62 |
| Cullinan, Amy E; Lindstrom, Mary J; Sabet, Sina et al. (2004) Evaluation of the antitumor effects of Herpes simplex virus lacking ribonucleotide reductase in a murine retinoblastoma model. Curr Eye Res 29:167-72 |
| Audo, Isabelle; Darjatmoko, Soesiawati R; Schlamp, Cassandra L et al. (2003) Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci 44:4192-9 |
Showing the most recent 10 out of 84 publications
